The effect of tranexamic acid on blood loss in bimaxillary orthognathic surgery.
Not Applicable
- Conditions
- Jaw defomities
- Registration Number
- JPRN-UMIN000018115
- Lead Sponsor
- Tokyo Metropolitan Ohtsuka Hospital
- Brief Summary
It has been suggested that TXA may be able to reduce intraoperative blood loss during orthognathic surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 99
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria are atrial fibrillation, coronary artery disease treated with drug eluting stent, severe choronic renal failure, congenital or acquried thrombophillia, and known or suspected allergy to tranexamic acid.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method intraoperative blood loss
- Secondary Outcome Measures
Name Time Method